[Skip to Content]
[Skip to Content Landing]
Citations 0
January 9, 2002

Ramipril and Risk of Diabetes

Author Affiliations

Stephen J.LurieMD, PhD, Senior Editor


Not Available

JAMA. 2002;287(2):186. doi:10.1001/jama.287.2.186-JLT0109-1-2

To the Editor: Dr Yusuf and colleagues1 reported a reduction in the risk of developing diabetes during treatment with ramipril. However, examination of the data presented in Figure 1 reveals that the cumulative risk of developing diabetes in the placebo group at 2, 3, and 4 years of follow-up is approximately equal to the cumulative risk in the ramipril group at 3, 4, and 4.5 years, respectively. In other words, it appears that rather than preventing diabetes, treatment with ramipril only delays the recognition of diabetes by about 1 year.

First Page Preview View Large
First page PDF preview
First page PDF preview